Glenview Trust’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12M | Buy |
24,324
+110
| +0.5% | +$59.7K | 0.19% | 103 |
|
|
2025
Q4 | $14M | Buy |
24,214
+72
| +0.3% | +$40.7K | 0.22% | 89 |
|
|
2025
Q3 | $11.7M | Buy |
24,142
+631
| +3% | +$294K | 0.19% | 108 |
|
|
2025
Q2 | $9.53M | Sell |
23,511
-3,342
| -12% | -$1.4M | 0.16% | 117 |
|
|
2025
Q1 | $13.4M | Sell |
26,853
-1,923
| -7% | -$1.04M | 0.26% | 92 |
|
|
2024
Q4 | $15M | Sell |
28,776
-4,091
| -12% | -$2.25M | 0.28% | 86 |
|
|
2024
Q3 | $20.3M | Sell |
32,867
-24,510
| -43% | -$14.5M | 0.39% | 61 |
|
|
2024
Q2 | $31.7M | Buy |
57,377
+2,796
| +5% | +$1.6M | 0.64% | 34 |
|
|
2024
Q1 | $31.7M | Buy |
54,581
+7,771
| +17% | +$4.36M | 0.68% | 36 |
|
|
2023
Q4 | $24.8M | Sell |
46,810
-4,095
| -8% | -$1.98M | 0.61% | 45 |
|
|
2023
Q3 | $25.8M | Buy |
50,905
+12,369
| +32% | +$6.59M | 0.71% | 42 |
|
|
2023
Q2 | $20.1M | Buy |
38,536
+22,518
| +141% | +$12.2M | 0.55% | 52 |
|
|
2023
Q1 | $9.23M | Buy |
16,018
+150
| +0.9% | +$84.5K | 0.28% | 87 |
|
|
2022
Q4 | $8.74M | Sell |
15,868
-247
| -2% | -$131K | 0.29% | 88 |
|
|
2022
Q3 | $8.17M | Sell |
16,115
-308
| -2% | -$172K | 0.31% | 79 |
|
|
2022
Q2 | $8.92M | Sell |
16,423
-522
| -3% | -$287K | 0.33% | 81 |
|
|
2022
Q1 | $10M | Buy |
16,945
+26
| +0.2% | +$14.9K | 0.33% | 81 |
|
|
2021
Q4 | $11.3M | Sell |
16,919
-531
| -3% | -$332K | 0.37% | 72 |
|
|
2021
Q3 | $9.97M | Sell |
17,450
-216
| -1% | -$119K | 0.39% | 74 |
|
|
2021
Q2 | $8.91M | Sell |
17,666
-1,458
| -8% | -$688K | 0.34% | 81 |
|
|
2021
Q1 | $8.73M | Sell |
19,124
-1,345
| -7% | -$642K | 0.38% | 77 |
|
|
2020
Q4 | $9.53M | Sell |
20,469
-441
| -2% | -$207K | 0.44% | 70 |
|
|
2020
Q3 | $9.23M | Sell |
20,910
-1,356
| -6% | -$560K | 0.48% | 64 |
|
|
2020
Q2 | $8.07M | Sell |
22,266
-3,877
| -15% | -$1.3M | 0.46% | 64 |
|
|
2020
Q1 | $7.42M | Sell |
26,143
-6,788
| -21% | -$2.14M | 0.51% | 60 |
|
|
2019
Q4 | $10.7M | Sell |
32,931
-1,628
| -5% | -$494K | 0.6% | 54 |
|
|
2019
Q3 | $10.1M | Sell |
34,559
-1,084
| -3% | -$310K | 0.61% | 51 |
|
|
2019
Q2 | $10.5M | Sell |
35,643
-485
| -1% | -$134K | 0.65% | 46 |
|
|
2019
Q1 | $9.89M | Sell |
36,128
-3,301
| -8% | -$822K | 0.63% | 49 |
|
|
2018
Q4 | $8.82M | Sell |
39,429
-1,516
| -4% | -$356K | 0.65% | 47 |
|
|
2018
Q3 | $9.99M | Sell |
40,945
-2,154
| -5% | -$496K | 0.63% | 47 |
|
|
2018
Q2 | $8.93M | Sell |
43,099
-3,544
| -8% | -$752K | 0.66% | 44 |
|
|
2018
Q1 | $9.63M | Sell |
46,643
-5,263
| -10% | -$1.1M | 0.66% | 45 |
|
|
2017
Q4 | $9.86M | Buy |
51,906
+38
| +0.1% | +$7.28K | 0.68% | 46 |
|
|
2017
Q3 | $9.81M | Buy |
51,868
+18
| +0% | +$3.26K | 0.72% | 43 |
|
|
2017
Q2 | $9.05M | Buy |
51,850
+662
| +1% | +$111K | 0.7% | 50 |
|
|
2017
Q1 | $7.86M | Buy |
51,188
+2,002
| +4% | +$306K | 0.62% | 55 |
|
|
2016
Q4 | $6.94M | Buy |
+49,186
| New | +$7.25M | 0.58% | 59 |
|
|
2015
Q4 | $2.18M | Buy |
+15,344
| New | +$2.05M | 0.23% | 101 |
|
|
2014
Q4 | $570K | Buy |
+4,552
| New | +$554K | 0.06% | 152 |
|
|
2013
Q4 | $517K | Buy |
+4,641
| New | +$461K | 0.06% | 134 |
|
Other funds holding TMO
VCM
Glenview Trust's TMO Position: Q1 2026 in Review
Glenview Trust increased its Thermo Fisher Scientific (TMO) stake by 0.45% in Q1 2026, buying an estimated $59.7K and bringing the position to 24,324 shares worth $12M. The position accounts for 0.19% of the portfolio, ranked #103.
Glenview Trust first reported a position in TMO in Q4 2013 and has held it in 41 quarters since. The position peaked at $31.7M in Q2 2024. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Glenview Trust held 24,324 shares of Thermo Fisher Scientific worth $12M as of Q1 2026.
- Glenview Trust bought 110 Thermo Fisher Scientific shares in Q1 2026, an estimated $59.7K.
- Thermo Fisher Scientific made up 0.19% of Glenview Trust's portfolio in Q1 2026, its #103 holding.
- Glenview Trust first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 41 quarters since.
- Glenview Trust's Thermo Fisher Scientific position peaked at $31.7M in Q2 2024.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Glenview Trust's 13F filing for Q1 2026, filed 8 May 2026.